Modifications of coagulation imbalance during antithrombin treatment in preeclamptic patients: our experience
Critical Care2008Vol. 12(Suppl 2), pp. P213–P213
Citations Over TimeTop 21% of 2008 papers
Abstract
Preeclamptic conditions are often associated with a natural inhibitor consumption. Many studies have evidenced validity of antithrombin (AT) treatment during preeclamptic conditions. The aim of the study is to restore a congruous coagulation imbalance with administration of AT under the guide of thromboelastographic monitoring (TEG).
Related Papers
- → Comparative Performance of Three Anti–Factor Xa Heparin Assays in Patients in a Medical Intensive Care Unit Receiving Intravenous, Unfractionated Heparin(2006)35 cited
- Elimination of intravenously administered radiolabelled antithrombin III and heparin in humans.(1984)
- → Elimination of Intravenously Administered Radiolabelled Antithrombin III and Heparin in Humans(1984)20 cited
- → The heparin-catalysed inhibition of human factor XIa by antithrombin III is dependent on the heparin type(1988)5 cited
- → Comparative Performance of Three Anti-Factor Xa Heparin Assays in Patients in a Medical Intensive Care Unit Receiving Intravenous, Unfractionated Heparin(2006)1 cited